Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 V
Nivolumab/ipilimumab did not improve disease-free survival compared with chemotherapy in patients with ypN+ and/or R1 gastro-oesophageal adenocarcinoma following neoadjuvant chemotherapy and surgery.
Authors
- Sylvie Lorenzen
- Maike Collienne (ORCID: https://orcid.org/0000-0003-0932-2471)
- Irit Ben‐Aharon (ORCID: https://orcid.org/0000-0002-5839-5477)
- Guillaume Piessen (ORCID: https://orcid.org/0000-0001-8243-8310)
- S Daum (ORCID: https://orcid.org/0000-0003-0060-6013)
- C. Bugés Sánchez
- Kai‐Keen Shiu (ORCID: https://orcid.org/0000-0001-6202-9640)
- Ian Chau (ORCID: https://orcid.org/0000-0003-0286-8703)
- Radka Obermannová (ORCID: https://orcid.org/0000-0001-7363-7879)
- L. Wyrwicz
- Gertraud Stocker (ORCID: https://orcid.org/0009-0002-5999-6351)
- Barbara Merelli
- Ghazwan Al-Haidari
- Valérie Boige (ORCID: https://orcid.org/0000-0002-7817-4663)
- Virginia Arrazubi (ORCID: https://orcid.org/0000-0002-1431-2780)
- Florian Lordick (ORCID: https://orcid.org/0000-0001-8591-9339)
- Tania Fleitas (ORCID: https://orcid.org/0000-0002-2789-9082)
- Baruch Brenner (ORCID: https://orcid.org/0000-0002-1596-9362)
- C.A. Cella
- Ute Martens
- Antoine Giraud (ORCID: https://orcid.org/0000-0003-2158-3930)
- Carlos Gómez-Martín (ORCID: https://orcid.org/0000-0002-1929-0955)
- P Artru
- Peter Thuss‐Patience (ORCID: https://orcid.org/0000-0002-8544-9872)
- Magnus Nilsson (ORCID: https://orcid.org/0000-0002-6215-8132)
- Nicole C.T. van Grieken (ORCID: https://orcid.org/0000-0001-9992-0760)
- Antonio Avallone (ORCID: https://orcid.org/0000-0001-6188-5664)
- Marianne Sinn (ORCID: https://orcid.org/0000-0002-7155-1278)
- M. Mauer
- Elizabeth Smyth
Institutions
- Oslo University Hospital (NO)
- University College Hospital (GB)
- Karolinska University Hospital (SE)
- Universität Hamburg (DE)
- Masaryk University (CZ)
- Rabin Medical Center (IL)
- Churchill Hospital (GB)
- Rambam Health Care Campus (IL)
- Institut Gustave Roussy (FR)
- TUM Klinikum (DE)
- Hospital Universitario 12 De Octubre (ES)
- Ospedale Papa Giovanni XXIII (IT)
- Amsterdam Neuroscience (NL)
- University Medical Center Hamburg-Eppendorf (DE)
- Istituto Oncologico Veneto (IT)
- Navarre Institute of Health Research (ES)
- Masaryk Memorial Cancer Institute (CZ)
- Royal Marsden Hospital (GB)
- European Organisation for Research and Treatment of Cancer (BE)
- Hôpital Privé Jean Mermo (FR)
- Badalona Serveis Assistencials (ES)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Amsterdam University Medical Centers (NL)
- Hospital Municipal de Badalona (ES)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- SLK-Kliniken Heilbronn (DE)
- Hôpital Claude Huriez (FR)
- INCLIVA Health Research Institute (ES)
- University College London (GB)
- Franklin University (US)
- European Institute of Oncology (IT)
- Charité - Universitätsmedizin Berlin (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Leipzig University (DE)
Publication Details
- Journal
- Annals of Oncology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1016/j.annonc.2024.10.829
- Citations
- 37
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 15.50
Funders
- Bristol-Myers Squibb
- Astellas Pharma US
- GlaxoSmithKline
- Integrated BioBank of Luxembourg
- European Organisation for Research and Treatment of Cancer
- Manchester Biomedical Research Centre
- Janssen Pharmaceuticals